Liftstream is an executive search recruitment company in the life sciences sector
Amal Therapeutics raises seed funding for cancer immunotherapy
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Amal Therapeutics, bioValley, BIVF, Boehringer Ingelheim, Cancer immunotherapy, Dr Knut Elbers, High-Tech Grunderfonds, HTGF, Madiha Derouazi, multi-epitopic cellular immune response targeting cancer cells, oncology, University of Geneva
Leave a comment
GenSight investment profits from gene therapy buzz
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged Abingworth LLP, Bernard Gilly, Bluebird bio, Boehringer Ingelheim, celgene, Gene therapy, GenSight Biologics, Glybera, Index Ventures, Jen Bennet, Leber’s Hereditary Optic Neuropathy, Novartis Venture Funds, Paris, Professor Jose-Alain Sahel, Transgene, uniQure, University of Pennsylvania, Vision Institute
Leave a comment
Funding successes allow Promethera to look to clinical data in 2013
Authored by James Sheppard
Posted in Orphan Drugs and Rare Diseases
Tagged Allogenic Liver Cells, Boehringer Ingelheim, clinical, Crigler-Najjar, Eric Halioua, Etienne Sokal, funding, GMP, HepStem, Liftstream, Liftstream Rare Disease Day, Liver Fibrosis, Phenylketonuria, Promethera Bioscience, rare disease day, RDD13, regenerative medicine, Shire, Stem Cells
1 Comment